Small-diameter bacterial cellulose-based vascular grafts for coronary artery bypass grafting in a pig model.
cellulose
coronary artery
surgery
tissue engineering
vascular graft
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
02
2022
accepted:
22
08
2022
entrez:
13
10
2022
pubmed:
14
10
2022
medline:
14
10
2022
Statut:
epublish
Résumé
Surgical revascularization is the gold standard in most cases of complex coronary artery disease. For coronary artery bypass grafting, autologous grafts are state-of-the-art due to their long-term patency. A non-negligible amount of patients lack suitable bypass material as a result of concomitant diseases or previous interventions. As a promising alternative, tissue-engineered vascular grafts made of biomaterials such as bacterial cellulose (BC) are gaining more and more attention. However, the production of small-diameter grafts (inner diameter < 6 mm) of application-oriented length (> 5 cm) and their
Identifiants
pubmed: 36225961
doi: 10.3389/fcvm.2022.881557
pmc: PMC9548626
doi:
Types de publication
Journal Article
Langues
eng
Pagination
881557Informations de copyright
Copyright © 2022 Fusco, Meissner, Podesser, Marsano, Grapow, Eckstein and Winkler.
Déclaration de conflit d'intérêts
This study was supported by grants of the Department of Cardiac Surgery of the University Hospital Basel and the University of Basel awarded to the PI BW. Another grant from Jubilaeumsstiftung/Novartis was awarded to BW for a visiting fellowship for tissue engineering. Further, BW, MG, and FE were supported from Vascular Graft Solutions (VGS, Tel Aviv-Jaffa, Israel). No other potential conflict of interest relevant to this article was reported. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Vasc Surg. 2004 Jul;40(1):146-53
pubmed: 15218475
Biomaterials. 2009 Mar;30(8):1542-50
pubmed: 19111338
Am Surg. 1982 Dec;48(12):622-7
pubmed: 6218768
Circulation. 1978 Jun;57(6):1070-74
pubmed: 346259
Eur J Cardiothorac Surg. 2011 Aug;40(2):394-8
pubmed: 21216613
Nat Med. 2006 Mar;12(3):361-5
pubmed: 16491087
J Vasc Surg. 2010 Jul;52(1):176-95
pubmed: 20299181
J Biomed Mater Res B Appl Biomater. 2011 Apr;97(1):105-13
pubmed: 21290588
Biotechnol Adv. 2015 Dec;33(8):1547-71
pubmed: 26253857
Biomater Sci. 2020 Aug 21;8(16):4383-4395
pubmed: 32643723
Can J Surg. 1980 Nov;23(6):544-6
pubmed: 6449992
Biotechnol Bioeng. 2007 Jun 1;97(2):425-34
pubmed: 17195972
Br J Surg. 1994 Sep;81(9):1254-69
pubmed: 7953384
Front Bioeng Biotechnol. 2018 Apr 17;6:41
pubmed: 29721495
Int J Biol Macromol. 2017 Nov;104(Pt A):97-106
pubmed: 28587970
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Eur J Vasc Endovasc Surg. 2009 May;37(5):592-6
pubmed: 19231251
Scand Cardiovasc J. 2012 Feb;46(1):57-62
pubmed: 22029845
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
N Engl J Med. 2018 May 31;378(22):2069-2077
pubmed: 29708851